Compared with their adjacent noncancerous tissues, tumor tissues exhibited the consistent downregulation mRNA of CYP26A1 and CYP26B1 in patients number 2, 3, 5, and 6 (expression >2-fold change in numbers 2, 3, and 5). This evidence concerns the gene CYP26A1 and neoplasm.